Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-001630
Filing Date
2006-03-16
Accepted
2006-03-15 21:04:34
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. FORM 10-K b58494ipe10vk.htm 10-K 1081761
2 EX-3.3 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION b58494ipexv3w3.txt EX-3.3 2557
3 EX-10.14 AMEND NO.3 TO DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT b58494ipexv10w14.txt EX-10.14 14167
4 EX-10.48 SUMMARY OF RELOCATION ADJUSTMENT b58494ipexv10w48.txt EX-10.48 1948
5 EX-23.1 CONSENT OF PRICEWATERHOUSE COOPERS LLP b58494ipexv23w1.txt EX-23.1 891
6 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b58494ipexv31w1.txt EX-31.1 4145
7 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b58494ipexv31w2.txt EX-31.2 4121
8 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b58494ipexv32w1.txt EX-32.1 1735
9 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b58494ipexv32w2.txt EX-32.2 1734
  Complete submission text file 0000950135-06-001630.txt   1114514
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

EIN.: 450478605
Type: 10-K | Act: 34 | File No.: 000-49839 | Film No.: 06689845
SIC: 2834 Pharmaceutical Preparations